SCHEMBL28487262

SCHEMBL28487262

COc1ccc2nc(Cc3ccccc3)n(CCCc3ccccc3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 5/20 0.47
TP53 P04637 3/20 0.47
BRD4 O60885 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ACSS2 Q9NR19 1/20 0.46
MC4R P32245 1/20 0.45
PLA2G2A P14555 1/20 0.45
LMNA P02545 2/20 0.45
RECQL P46063 1/20 0.45
SIGMAR1 Q99720 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29411875 1.00 L3MBTL1 (0.49) L3MBTL1MAPTTP53BRD4SMN1; SMN2
SCHEMBL29412097 0.92 L3MBTL1 (0.50) L3MBTL1MAPTTP53BRD4ACSS2
SCHEMBL29412148 0.88 MAPT (0.53) L3MBTL1MAPTTP53BRD4SMN1; SMN2
SCHEMBL9122314 0.87 JAK2 (0.54) MAPTTP53BRD4SMN1; SMN2ACSS2
SCHEMBL28480003 0.83 BRD4 (0.57) L3MBTL1MAPTTP53BRD4SMN1; SMN2
SCHEMBL29411941 0.81 BRD4 (0.52) L3MBTL1MAPTTP53BRD4SMN1; SMN2
SCHEMBL29412041 0.81 KDM4E (0.56) L3MBTL1MAPTTP53BRD4SMN1; SMN2
SCHEMBL29411955 0.80 TP53 (0.54) L3MBTL1MAPTTP53BRD4SMN1; SMN2
SCHEMBL29411994 0.79 TP53 (0.58) L3MBTL1MAPTTP53BRD4SMN1; SMN2
SCHEMBL29412011 0.79 BRD4 (0.50) L3MBTL1MAPTTP53BRD4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111978301-B Benzimidazole compound with endothelial lipase inhibition effect and application thereof 盐城师范学院 2022-08-02 CN disclosed
CN-111978301-A Benzimidazole compound with endothelial lipase inhibition effect and application thereof 盐城师范学院 2020-11-24 CN disclosed